$24.82
-1.33-5.09%
À la clôture: Nov 16, 4:00 PM EST
$24.39
-0.43-1.73%
Après les heures: 5:19 PM EST

Rapport Therapeutics (RAPP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.84 | $-1.22 | 31.1 % |
| Q2 | Aug 5, 2026 | $-1.19 | $-0.97 | -22.7 % |
| Q1 | May 7, 2026 | $-0.42 | $-0.68 | 38.2 % |
| Q4 | Mar 10, 2026 | $-0.72 | $-0.66 | -9.09 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0 | $4.00M | -100.0 % |
| Q1 | May 7, 2026 | $20.00M | $8.80M | 127.3 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.22 | $-0.97 | $-0.68 | $-0.66 |
| Actual | $-0.84 | $-1.19 | $-0.42 | $-0.72 |
| Surprise | +31.1% | -22.7% | +38.2% | -9.09% |
| Revenue | ||||
| Estimate | — | $4.0M | $8.8M | — |
| Actual | $0 | $0 | $20.0M | $0 |
| Surprise | — | -100.0% | +127.3% | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.83 | $-0.92 | $-1.01 | $-1.10 |
| Revenue | ||||
| Consensus | $7140 | — | — | — |